Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
102 USD | +0.01% | +5.95% | +2.00% |
05-13 | Legend Biotech 1Q Loss Narrows with Higher Carvykti Sales | DJ |
05-10 | Novartis’ Scemblix Gets Third US FDA Breakthrough Therapy Designation | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- NOVN Stock
- NVSEF Stock
- Revisions Novartis AG